Guinea vs Mozambique: Antiretroviral therapy coverage for PMTCT
Guinea
80.0%
in 2024
Mozambique
82.0%
in 2024
Guinea rank
41st
Mozambique rank
38th
Antiretroviral therapy coverage for PMTCT over time
- Guinea
- Mozambique
How they compare
Mozambique currently reports 82.0% against 80.0% in Guinea, a difference of 2.0%.
Across all 25 years both countries report, Mozambique has been ahead every year.
Guinea ranks 41st and Mozambique ranks 38th of 84 countries.
Mozambique has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.3% | 18.0% | 10.7% | Mozambique |
| 2010s | 19.6% | 65.8% | 46.2% | Mozambique |
| 2020s | 63.8% | 81.0% | 17.2% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Guinea or Mozambique?
- Mozambique, at 82.0% against 80.0% in Guinea as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Guinea and Mozambique?
- 2.0%, with Mozambique ahead.
- How many years of comparable data are there for Guinea and Mozambique?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea and Mozambique rank globally for antiretroviral therapy coverage for pmtct?
- Guinea ranks 41st and Mozambique ranks 38th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).